Show
Sort by
-
Repeated OGTT versus continuous glucose monitoring for predicting development of stage 3 type 1 diabetes : a longitudinal analysis
-
Use of culture to reach metabolically adequate beta-cell dose by combining donor islet cell isolates for transplantation in type 1 diabetes patients
-
Zusto : a new sweetening agent with low glycemic index
-
Age and early graft function relate with risk-benefit ratio of allogenic islet transplantation under antithymocyte globulin-mycophenolate mofetil-tacrolimus immune suppression
-
Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients
-
Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes